Linden Capital Partners Portfolio

Linden Capital Partners Portfolio Summary

Linden Capital Partners’ most common sectors for investment arehealthcare services (28%) and life science (21%) . The Firm’s most common investment types include secondary buyout (38%) and buyout (lbo, mbo, mbi) (28%). In total, Linden Capital Partners has invested in 17 US states and 2 different countries.

Sign-up to view Linden Capital Partners’ full profile and discover more large private equity firm investors just like it.

Portfolio Summary

  • Total Sectors Invested 14
  • Total Countries Invested 2

Linden Capital Partners

Linden Capital Partners LLC

110 N. Wacker Drive 55th Floor,
Chicago, Illinois 60606
United States
(312) 506-5600
www.lindenllc.com
info@lindenllc.com

All (51) Current (24) Exited (27)
Status Dates Company Description
Investment    Exit       
Current 2024-03-12 - Alcresta Therapeutics
Life Science
Newton, Massachusetts
www.alcresta.com
Alcresta Therapeutics is a specialty pharmaceutical company focusing on discovering and developing a new generation of enzyme-based products that improve digestion and absorption of important nutrients. The company's lead program is a point-of-care, enzyme-based product that improves the bioavailability of long-chain fatty acids (such as DHA, EPA, and AA) for patients with impaired pancreatic output. Compromised pancreatic function is a complication of many diseases such as cystic fibrosis, chronic pancreatitis, and cancer as well as developmental immaturity, and Alcresta's products are aimed at meeting the nutritional needs of these patients. Alcresta Therapeutics was formed in 2011 and is based in Newton, Massachusetts.

Acquired From Val
Frazier Healthcare Partners PE , Athyrium Capital Management PE -

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.